MN-25 (also known as MN 25, 7-Methoxy-1-(2-morpholinoethyl)-N-((1S,4R)-1,3,3-trimethylbicyclo(2.2.1)heptan-2-yl)-1H-indole-3-carboxamide, (N-((S)-Fenchyl)-1-(2-(morpholin-4-yl)ethyl)-7-methoxyindole-3-carboxamide, 7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide, N-(S)-Fenchyl-1-(2-morpholinoethyl)-7-methoxyindole-3-carboxamide or 7-methoxy-1-[2-(morpholin-4-yl)ethyl]-N-[(1s,2s,4r)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1h-indole-3-carboxamide) is a substance of the aminoalkylindole class.
Chemistry
Legal status
Canada: MN-25 is a Schedule II substance.
Germany: MN-25 is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".